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Results of this study highlight the 
need of a deeper surveillance, 
legislation and analysis of 
dietary supplements, 
in order to ensure
consumers safety. 
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INTRODUCTION
Dietary supplements for weight loss are one of the
best-selling products outside the pharmaceutical
distribution network. They often contain plants in
their composition, which are known sources of toxic
elements (Rebiere et al. 2012; Zin 2014).
WORK PURPOSES
• To compare the concentration of elemental
impurities (Cr, Cu, Ir, Mn, Mo, Ni, Os, Pb, Pt, Rh and
Ru) found in dietary supplements for weight loss with
specified limits set by international agencies;
• To assess the cumulative non-carcinogenic risk to
human health due to exposure to mixtures of such
elements.
MATERIALS & METHODS
• Samples: 25 dietary supplements for weight loss,
randomly purchased in 5 different suppliers in Portugal.
• Analytical Technique: Wavelength Dispersive X ray
Fluorescence (WDXRF) spectrometry (Figueiredo et al.
2016), using a 4 kW WDXRF spectrometer (S4 Pioneer,
Bruker AXS).
• All reagents were of high analytical grade (≥99% Reagent 
or Ph. Eur.).
• Risk assessment: performed according to Environmental 
Protection Agency (EPA) guidelines, through the Hazard 
Index (HI) (U.S. EPA 2001).
CONCLUSIONS
Table 1. Elemental impurities concentrations measured in 25 dietary supplements  
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LABEL
DISCREPANCIES
1 Supplement
Label: Cr as active ingredient
Result of analysis: not detected
2 Supplements Measured Cr levels << Labeled values
25 Dietary
Supplements
2 Supplements with Cr > limit
1 Supplement = Pb + Mn > limit
(both neurotoxic)
Figure 1. Label discrepancies found in the analyzed dietary supplements
• Some of the analyzed dietary supplements revealed high
levels of Mn and Pb above the imposed limit.
• Risk Assessment did not reveal non-carcinogenic effects to
human health (HI<1). However, these results only reflect the
intake of these elements through dietary supplements
consumption and do not consider the cumulative risk
associated with other routes of exposure.
• Unconformities were detected between the labeled and the
determined values of Cr.
HQ- Hazard Quotient; n.a. - not applicable
a Levels expressed as median, minimum and maximum in brackets; b 40  µg/day (Reference daily dose 
for Cr as ingredient)
Element Concentration a 
(µg/g) 
Legal limit  (µg/g) Number of 
samples  
>  limit 
HQ  
(median) 
HQ  
(max) 
Dietary 
Supplements 
 Drug 
Products
 
Cr  42.54 (22.19; 63.12) - b 25 2 3.4E-4 5.0E-4 
Mn  99.77 (66.63; 896.08) - 250 1 8.5E-3 7.7E-2 
Mo  7.13 (5.57; 10.44) - 25 0 1.7E-2 2.5E-2 
Os  2.84 (2.19; 3.39) - 10 0 n.a n.a. 
Pb  2.04 (1.74; 2.48) 1 0.5 1 6.8E-3 8.3E-3 
      HI 3.3E-2 1.1E-1 
RESULTS
